Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of brivudine tablets for acute herpes zoster
ChiCTR2600121903Phase 4Recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of brivudine in herpes zoster (HZ), sponsored by The Second Xiangya Hospital. Primary endpoints: Acute phase VAS score at the end of treatment, Pain relief time and 5 more. Started Apr 2026; status: recruiting.
02
Drugs
brivudine
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on ChiCTR2600121903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600121903.